Cue Biopharma (CUE) earnings · rev $27.5M
These earnings events as JSON? API free 100/dayCue Biopharma (CUE) is a biotechnology company listed on US.
This CUE earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CUE revenue for 2025-12-31 was $27.5M. Net income was -$26.6M. Revenue was up 195.7% from 2024-12-31 to 2025-12-31. CUE currently screens at market cap $59.5M.
When the next CUE 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 195.7% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full CUE research stays on the stock page; the tape stays on the quote page.
CUE earnings FAQ
What are CUE's latest revenue and net income?
Latest cached Cue Biopharma (CUE) revenue for Dec 31, 2025 was $27.5M. Net income was -$26.6M. Statements: https://lician.com/financials/cue
What is CUE's latest diluted EPS?
Latest cached Cue Biopharma (CUE) diluted EPS for Dec 31, 2025 was -$0.28.
What period does the latest CUE earnings print cover?
The latest cached Cue Biopharma (CUE) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did CUE revenue change from the prior cached period?
Cached Cue Biopharma (CUE) revenue was up 195.7% from $9.3M (Dec 31, 2024) to $27.5M (Dec 31, 2025). Statements: https://lician.com/financials/cue
Where are CUE earnings listed?
Cached earnings facts for Cue Biopharma (CUE) are listed at https://lician.com/earnings/cue. Statements: https://lician.com/financials/cue
Not investment advice.